The 3rd Global Insight Conference on Breast Cancer has been developed more than 15 years ago to specifically provide the audience of breast cancer professionals and scientists with education and discussion on progress in the field. The faculty of international experts was selected to present the most exciting areas of innovation related to breast cancer and to discuss issues of significant controversy. Breast cancer represents the front runner in cancer research in many aspects. The Programme of this Conference includes lectures on molecular characterization, epidemiology, detection and diagnosis, metastatic breast cancer, updated treatments of early and advanced disease, surgery & radiotherapy, management of difficult cases and hereditary syndromes.
We welcome medical oncologists, pathologists, breast surgeons, radiation oncologists and basic scientists to listen to breast cancer leaders and to exchange experiences in a friendly atmosphere. Taking advantage of the unique offerings of Valencia, there will be a limited number of attractive options for those wishing to extend their stay and bring their families with pre and post tours of Valenia. Leisure time activities for delegates and guests will be offered to take full advantage of Valencia.
Mark your calendars now and stay tuned for more information. See you soon in Valencia, Spain.
Older and younger women benefit equally from breast reconstruction; age shouldn’t disqualify a woman from having reconstruction
Nearly 33% of women diagnosed with breast cancer aren’t receiving an annual mammogram after treatment
A study suggests that black women younger than 45 may have a higher risk of hormone-receptor-negative breast cancer if they have three or more children, never breastfeed, or have more abdominal fat
A study suggests that the molecular subtype of a metastatic, hormone-receptor-positive breast cancer may help women and their doctors make treatment decisions
Breast Cancer Now launches #43paday campaign, calling on Jeremy Hunt to clarify who is responsible for funding cheap drugs that can help prevent spread of breast cancer
Our response following NICE's draft decision to approve breast cancer drug Afinitor
Researchers have developed a novel method for delivering therapeutic molecules into cells.
Copyrights © 2016-17 Innovinc Pvt Ltd All Rights Reserved